| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 房地产业务(元) | 449,868,897.00 | 755,763,649.19 | 456,236,091.92 | 914,389,266.57 | 96,568,105.52 |
| 服务业(元) | 23,753,363.40 | 43,412,771.43 | 20,166,829.76 | 38,353,707.41 | 18,281,789.93 |
| 制药业(元) | 6,129,313,748.41 | 12,666,450,897.76 | 6,162,368,839.78 | 13,613,296,638.00 | 6,053,212,018.31 |
| 营业成本(元) | |||||
| 房地产业务(元) | 385,608,573.12 | 555,198,205.94 | 361,476,465.08 | 709,100,422.44 | - |
| 服务业(元) | 13,184,832.51 | 29,443,140.68 | 14,122,665.45 | 28,426,667.34 | - |
| 制药业(元) | 700,594,876.07 | 1,337,972,913.46 | 645,224,498.66 | 1,306,422,816.34 | 617,771,629.64 |
| 毛利(元) | |||||
| 房地产业务(元) | 64,260,323.88 | 200,565,443.25 | 94,759,626.84 | 205,288,844.13 | - |
| 服务业(元) | 10,568,530.89 | 13,969,630.75 | 6,044,164.31 | 9,927,040.07 | - |
| 制药业(元) | 5,428,718,872.34 | 11,328,477,984.30 | 5,517,144,341.12 | 12,306,873,821.66 | 5,435,440,388.67 |
| 毛利率(%) | |||||
| 房地产业务(%) | 14.28 | 26.54 | 20.77 | 22.45 | - |
| 服务业(%) | 44.49 | 32.18 | 29.97 | 25.88 | - |
| 制药业(%) | 88.57 | 89.44 | 89.53 | 90.40 | 89.79 |
| 收入构成(%) | |||||
| 房地产业务(%) | 6.81 | 5.61 | 6.87 | 6.28 | 1.57 |
| 服务业(%) | 0.36 | 0.32 | 0.30 | 0.26 | 0.30 |
| 制药业(%) | 92.83 | 94.07 | 92.82 | 93.46 | 98.14 |
| 毛利构成(%) | |||||
| 房地产业务(%) | 1.17 | 1.74 | 1.69 | 1.64 | 0.00 |
| 服务业(%) | 0.19 | 0.12 | 0.11 | 0.08 | 0.00 |
| 制药业(%) | 98.64 | 98.14 | 98.21 | 98.28 | 100.00 |